GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DT&CRO Co Ltd (XKRX:383930) » Definitions » Stock Based Compensation

DT&CRO Co (XKRX:383930) Stock Based Compensation : ₩28 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is DT&CRO Co Stock Based Compensation?

DT&CRO Co's Stock Based Compensation for the three months ended in Mar. 2024 was ₩23 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was ₩28 Mil.


DT&CRO Co Stock Based Compensation Historical Data

The historical data trend for DT&CRO Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DT&CRO Co Stock Based Compensation Chart

DT&CRO Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
51.39 60.06 229.17 31.71

DT&CRO Co Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.85 23.20 23.46 -41.80 23.00

DT&CRO Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩28 Mil.


DT&CRO Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of DT&CRO Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


DT&CRO Co (XKRX:383930) Business Description

Traded in Other Exchanges
N/A
Address
28, Baengnyeong-ro 20beon-gil, 2nd, 3rd, 4th floor, Na-dong, Cheoin-gu, Gyeonggi-do (Yubang-dong), Yongin-si, KOR, 17042
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.

DT&CRO Co (XKRX:383930) Headlines

No Headlines